Sr. Manager / Associate Director, New Product Planning - Kite at Gilead Sciences

Tokyo, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, OncologyIndustries

Requirements

Knowledgeable and motivated professional capable of working effectively in a cross-functional team environment
High level of business acumen in analyzing and coordinating activities from identified industry trends, competitor’s resources and practices

Responsibilities

Develop the commercial strategy and action plans for early products in Japanese market by leveraging the global and regional strategy and plans
Develop effective working relationships with opinion leaders and other key stakeholders to establish Kite’s pipeline in Japan
Partner with Clinical team, Medical Affairs, Government and Public Affairs to ensure effective development and implementation of strategies
Utilize high level of business acumen in analyzing and coordinating activities from identified industry trends, competitor’s resources and practices
Collaborate with the regional marketing team to share local market insights that can inform the development of global brand plans
Develop and implement the promotional communication strategy and tactics ensuring alignment with the overall brand strategy
Work alongside the global, US, EU and international marketing colleagues to develop and produce compliant promotional materials
Manage external agency relationships (i.e., advertising, public relations, medical education vendors) to develop promotional deliverables
Manage the marketing budget (OPEX) and project timelines
Drive excellence in commercial activities

Skills

Product Planning

Biopharmaceuticals

Oncology

Cell Therapy

Immunotherapy

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free